Latest News
Benefits using Technegas
Technegas offers significant advantages over all other agents because it behaves as a true gas allowing its nano-sized particles to penetrate deep into the alveoli where they remain bound to the lining of the alveoli resulting in a very stable image of the highest quality. Showing a higher sensitivity and specificity result over traditional planar V/Q, Technegas is considered the agent of choice for quality SPECT-VQ.
Proven diagnostic accuracy
Sensitivity, specificity and accuracy at least the equivalent of CTPA giving the clinician interpretive confidence first time, every time.
Plus these specific benefits:
- Non invasive
Aids patient comfort and compliance.
Aids patient comfort and compliance.
- Detects PE
Even on the subsegmental levels.
Even on the subsegmental levels.
- Proven track record
More than 21 years and 20million scans worldwide without a single documented adverse event.
More than 21 years and 20million scans worldwide without a single documented adverse event.
- Low radiation burden to the patient
in compliance with ALARA principles and FDA recommendation, Technegas is the right exam, for the right reason, at the right time.
in compliance with ALARA principles and FDA recommendation, Technegas is the right exam, for the right reason, at the right time.
- A true 'screening' test
A true screening test should have universal application and minimal exclusion criteria. Technegas may be administered to almost all patients including those who are -
- Comatose
- Renally compromised
- Diabetics on Metoformin
- Critically ill
- Suffered from M.I.
- Allergic iodinated contrast
- Claustrophobic
- On long term anticoagulants
- Receiving ventilatory supports
- Female under 45
A true screening test should have universal application and minimal exclusion criteria. Technegas may be administered to almost all patients including those who are -
- Comatose
- Renally compromised
- Diabetics on Metoformin
- Critically ill
- Suffered from M.I.
- Allergic iodinated contrast
- Claustrophobic
- On long term anticoagulants
- Receiving ventilatory supports
- Female under 45
